GFOR vs. ALBT, KLTO, ONVO, CELZ, OMGA, APTO, FRTX, CERO, GENE, and TTNP
Should you be buying Graf Acquisition Corp IV stock or one of its competitors? The main competitors of Graf Acquisition Corp IV include Avalon GloboCare (ALBT), Klotho Neurosciences (KLTO), Organovo (ONVO), Creative Medical Technology (CELZ), Omega Therapeutics (OMGA), Aptose Biosciences (APTO), Fresh Tracks Therapeutics (FRTX), CERo Therapeutics (CERO), Genetic Technologies (GENE), and Titan Pharmaceuticals (TTNP). These companies are all part of the "biological products, except diagnostic" industry.
Graf Acquisition Corp IV vs.
Graf Acquisition Corp IV (NYSE:GFOR) and Avalon GloboCare (NASDAQ:ALBT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.
Graf Acquisition Corp IV and Avalon GloboCare both received 0 outperform votes by MarketBeat users.
28.5% of Graf Acquisition Corp IV shares are owned by institutional investors. Comparatively, 1.4% of Avalon GloboCare shares are owned by institutional investors. 20.0% of Graf Acquisition Corp IV shares are owned by company insiders. Comparatively, 37.3% of Avalon GloboCare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Graf Acquisition Corp IV has a net margin of 0.00% compared to Avalon GloboCare's net margin of -1,125.59%. Avalon GloboCare's return on equity of 0.00% beat Graf Acquisition Corp IV's return on equity.
Graf Acquisition Corp IV has a beta of 0.17, indicating that its stock price is 83% less volatile than the S&P 500. Comparatively, Avalon GloboCare has a beta of -0.11, indicating that its stock price is 111% less volatile than the S&P 500.
In the previous week, Avalon GloboCare had 19 more articles in the media than Graf Acquisition Corp IV. MarketBeat recorded 19 mentions for Avalon GloboCare and 0 mentions for Graf Acquisition Corp IV. Avalon GloboCare's average media sentiment score of 0.21 beat Graf Acquisition Corp IV's score of 0.00 indicating that Avalon GloboCare is being referred to more favorably in the news media.
Graf Acquisition Corp IV has higher earnings, but lower revenue than Avalon GloboCare.
Summary
Graf Acquisition Corp IV and Avalon GloboCare tied by winning 5 of the 10 factors compared between the two stocks.
Get Graf Acquisition Corp IV News Delivered to You Automatically
Sign up to receive the latest news and ratings for GFOR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Graf Acquisition Corp IV Competitors List
Related Companies and Tools
This page (NYSE:GFOR) was last updated on 3/13/2025 by MarketBeat.com Staff
